The DOI matches its Crossref record; 264 of the 264 references it cites were found in a registry or an index.
The epidemiology of human papillomavirus infections
Open accessAbstract
Infection with oncogenic human papillomavirus (HPV) types is a necessary cause of cervical cancer, the second most frequently occurring cancer in women worldwide. Rates of acquisition of HPV are high, particularly among sexually active young adults. Reported estimates of incident HPV infection among initially negative women have reached as high as 60% over a 5-year follow-up period. In this article, we review the epidemiology of HPV infection. In addition to estimates of disease frequency, we highlight risk factors for HPV infection, including the number of lifetime sex partners, which is the most salient risk factor. We discuss significant issues surrounding the natural history of HPV infection, including viral persistence versus clearance, immune response, development of lesions and development of cancer. Finally, we discuss strategies for preventing HPV infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase
Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., & Erlich, H. A. (1988) · Science · doi:10.1126/science.2448875 · Cited by 17,719
SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,775
Epidemiologic classification of human papillomavirus types associated with cervical cancer
Muñoz, N., Bosch, F. X., de Sanjosé, S., Herrero, R., Castellsagué, X., Shah, K. V., Snijders, P. J. F., & Meijer, C. J. L. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021641 · Cited by 6,249
Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective
Bosch, F. X., Manos, M. M., Munoz, N., Sherman, M., Jansen, A. M., Peto, J., Schiffman, M. H., Moreno, V., Kurman, R., Shan, K. V., et al. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.11.796 · Cited by 3,370
SEER Cancer Statistics Review, 1975-2008, National Cancer Institute, Bethesda, MD
Howlader, N. (2011) · Medical Entomology and Zoology · Cited by 2,612
Natural History of Cervicovaginal Papillomavirus Infection in Young Women
Ho, G. Y. F., Bierman, R., Beardsley, L., Chang, C. J., & Burk, R. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802123380703 · Cited by 2,329
NATURAL HISTORY OF CERVICOVAGINAL PAPILLOMAVIRUS INFECTION IN YOUNG WOMEN
Loria, G. R., Ierman, R. O. B., Eardsley, L. E. B., & Hang, H. J. C. (1998) · Cited by 1,890
A Controlled Trial of a Human Papillomavirus Type 16 Vaccine
Koutsky, L. A., Ault, K. A., Wheeler, C. M., Brown, D. R., Barr, E., Alvarez, F. B., Chiacchierini, L. M., & Jansen, K. U. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020586 · Cited by 1,602
Self-citationNATURAL HISTORY OF CERVICAL INTRAEPITHELIAL NEOPLASIA
RICHART, R. M. (1967) · Clinical Obstetrics and Gynecology · doi:10.1097/00003081-196712000-00002 · Cited by 1,376
Blaustein's Pathology of the Female Genital Tract
(2019) · Springer eBooks · doi:10.1007/978-3-319-46334-6 · Cited by 1,335
Cited by
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Human papillomavirus and cervical cancer
Schiffman, M., Castle, P. E., Jeronimo, J., Rodriguez, A. C., & Wacholder, S. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61416-0 · Cited by 2,985
The Biology and Life-Cycle of Human Papillomaviruses
Doorbar, J., Quint, W., Banks, L., Bravo, I. G., Stoler, M., Broker, T. R., & Stanley, M. A. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.06.083 · Cited by 1,528
The Estimated Lifetime Probability of Acquiring Human Papillomavirus in the United States
Chesson, H. W., Dunne, E. F., Hariri, S., & Markowitz, L. E. (2014) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000193 · Cited by 706
The epidemiology of genital human papillomavirus infection
Trottier, H., & Franco, E. L. (2006) · Vaccine · doi:10.1016/j.vaccine.2005.09.054 · Cited by 686
Chapter 6: Epidemiology and transmission dynamics of genital HPV infection
Burchell, A. N., Winer, R. L., de Sanjosé, S., & Franco, E. L. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.031 · Cited by 529
Model for Assessing Human Papillomavirus Vaccination Strategies
Elbasha, E. H., Dasbach, E. J., & Insinga, R. P. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1301.060438 · Cited by 491
Block, S. L., Nolan, T., Sattler, C., Barr, E., Giacoletti, K. E. D., Marchant, C. D., Castellsagué, X., Rusche, S. A., Lukac, S., Bryan, J. T., et al. (2006) · Pediatrics · doi:10.1542/peds.2006-0461 · Cited by 484
HPV‐mediated cervical carcinogenesis: concepts and clinical implications
Snijders, P. J., Steenbergen, R. D., Heideman, D. A., & Meijer, C. J. (2006) · The Journal of Pathology · doi:10.1002/path.1866 · Cited by 455
De Vito, C., Angeloni, C., De Feo, E., Marzuillo, C., Lattanzi, A., Ricciardi, W., Villari, P., & Boccia, S. (2014) · BioMed Research International · doi:10.1155/2014/304602 · Cited by 451
Prophylactic human papillomavirus vaccines
Lowy, D. R. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28607 · Cited by 428
Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions
Steenbergen, R. D. M., Snijders, P. J. F., Heideman, D. A. M., & Meijer, C. J. L. M. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3728 · Cited by 386
Heck, J. E., Berthiller, J., Vaccarella, S., Winn, D. M., Smith, E. M., Shan'gina, O., Schwartz, S. M., Purdue, M. P., Pilarska, A., Eluf-Neto, J., et al. (2010) · International Journal of Epidemiology · doi:10.1093/ije/dyp350 · Cited by 385
Protein–protein interactions in human disease
RYAN, D., & MATTHEWS, J. (2005) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2005.06.001 · Cited by 375
An Armamentarium of Wart Treatments
Lipke, M. M. (2006) · Clinical Medicine & Research · doi:10.3121/cmr.4.4.273 · Cited by 344
Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems
Garçon, N., & Van Mechelen, M. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.29 · Cited by 314
Gerend, M. A., & Magloire, Z. F. (2008) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2007.08.022 · Cited by 283
Using message framing to promote acceptance of the human papillomavirus vaccine.
Gerend, M. A., & Shepherd, J. E. (2007) · Health Psychology · doi:10.1037/0278-6133.26.6.745 · Cited by 283
Functional signatures of protective antiviral T‐cell immunity in human virus infections
Harari, A., Dutoit, V., Cellerai, C., Bart, P., Du Pasquier, R. A., & Pantaleo, G. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00395.x · Cited by 273
Tota, J. E., Chevarie-Davis, M., Richardson, L. A., deVries, M., & Franco, E. L. (2011) · Preventive Medicine · doi:10.1016/j.ypmed.2011.08.017 · Cited by 261
Epidemiology of Mucosal Human Papillomavirus Infection and Associated Diseases
Trottier, H., & Burchell, A. N. (2009) · Public Health Genomics · doi:10.1159/000214920 · Cited by 156
Vaccines to Prevent Infections by Oncoviruses
Schiller, J. T., & Lowy, D. R. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134019 · Cited by 101
Petäjä, T., Pedersen, C., Poder, A., Strauss, G., Catteau, G., Thomas, F., Lehtinen, M., & Descamps, D. (2011) · International Journal of Cancer · doi:10.1002/ijc.25887 · Cited by 91
Lifestyle and socio-demographic factors associated with high-risk HPV infection in UK women
on behalf of the TOMBOLA Group, Cotton, S. C., Sharp, L., Seth, R., Masson, L. F., Little, J., Cruickshank, M. E., Neal, K., & Waugh, N. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603822 · Cited by 65
“Our observation of decreasing hrHPV infection with increasing age (in all smear strata) is consistent with other UK, European and US series (Cuzick et al, 2003; Winer and Koutsky, 2004; Franceschi et al, 2006; Hibbitts et al, 2006).”
BackgroundResultInfluentialCdc6 contributes to abrogating the G1 checkpoint under hypoxic conditions in HPV E7 expressing cells
Chen, H., Zhang, Q., Qiao, L., Fan, X., Zhang, W., Zhao, W., & Chen, J. J. (2017) · Scientific Reports · doi:10.1038/s41598-017-03060-w · Cited by 10
Çelik, P., & İncesoy Özdemir, S. (2021) · Journal of Pediatric Infection · doi:10.5578/ced.202119803 · Cited by 3
Metadata
- Authors
- Baseman, J. G., & Koutsky, L. A.
- Venue
- Journal of Clinical Virology
- Publisher
- Elsevier BV
- Published
- 2005-03
- Volume
- 32
- Pages
- 16-24
- ISSN
- 1386-6532 (ISSN-L)
- OpenAlex
- W2129701815
- Cited by
- 955
- References
- 264
- FWCI
- 38.17
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.